PLSE Pulse Biosciences Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: PLSE

Price (delayed)

$7.82

Market cap

$431.86M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.88

Enterprise value

$396.64M

Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the potential to improve the quality of life for patients. The CellFX® System is the first ...

Highlights
The company's gross profit has surged by 100% QoQ and by 100% YoY
The company's debt has shrunk by 88% YoY and by 2.6% QoQ
The company's revenue has surged by 100% QoQ but it has shrunk by 100% YoY
The net income has increased by 28% year-on-year but it has declined by 7% since the previous quarter
The quick ratio has declined by 35% year-on-year and by 29% since the previous quarter
PLSE's equity is down by 15% since the previous quarter
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.pulsebiosciences.com
Peers: OBIO OM

Key stats

What are the main financial stats of PLSE
Market
Shares outstanding
55.23M
Market cap
$431.86M
Enterprise value
$396.64M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
9.69
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$43.57M
EBITDA
-$42.37M
Free cash flow
-$33.16M
Per share
EPS
-$0.88
Free cash flow per share
-$0.69
Book value per share
$0.81
Revenue per share
$0
TBVPS
$1.13
Balance sheet
Total assets
$59.15M
Total liabilities
$14.79M
Debt
$9.14M
Equity
$44.36M
Working capital
$38.62M
Liquidity
Debt to equity
0.21
Current ratio
6.76
Quick ratio
6.61
Net debt/EBITDA
0.83
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-62.5%
Return on equity
-115.4%
Return on invested capital
-143.1%
Return on capital employed
-83.1%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

PLSE stock price

How has the Pulse Biosciences stock price performed over time
Intraday
-2.86%
1 week
8.76%
1 month
-1.51%
1 year
-8.11%
YTD
-36.11%
QTD
-10.22%

Financial performance

How have Pulse Biosciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$43.57M
Net income
-$42.21M
Gross margin
N/A
Net margin
N/A
The company's revenue has surged by 100% QoQ but it has shrunk by 100% YoY
The company's gross profit has surged by 100% QoQ and by 100% YoY
The net income has increased by 28% year-on-year but it has declined by 7% since the previous quarter
The operating income has grown by 25% year-on-year but it has declined by 10% since the previous quarter

Growth

What is Pulse Biosciences's growth rate over time

Valuation

What is Pulse Biosciences stock price valuation
P/E
N/A
P/B
9.69
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
PLSE's EPS is up by 49% year-on-year
PLSE's equity is down by 15% since the previous quarter
The P/B is 6% below the 5-year quarterly average of 10.6
The company's revenue has surged by 100% QoQ but it has shrunk by 100% YoY

Efficiency

How efficient is Pulse Biosciences business performance
The ROIC has dropped by 79% since the previous quarter and by 28% year-on-year
PLSE's return on equity has surged by 76% year-on-year and by 27% since the previous quarter
The ROA has grown by 34% YoY but it has contracted by 14% from the previous quarter

Dividends

What is PLSE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PLSE.

Financial health

How did Pulse Biosciences financials performed over time
The total liabilities has plunged by 82% YoY but it has grown by 7% from the previous quarter
PLSE's current ratio is down by 35% YoY and by 29% from the previous quarter
The company's debt is 79% lower than its equity
The debt to equity has soared by 101% YoY and by 17% from the previous quarter
The company's debt has shrunk by 88% YoY and by 2.6% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.